extracorpor
membran
oxygen
ecmo
develop
critic
tool
permit
lung
protect
sever
respiratori
failur
use
larg
confin
acut
respiratori
distress
syndrom
howev
technolog
advanc
use
rang
respiratori
diseas
includ
asthma
context
nearfat
asthma
exacerb
ecmo
provid
manag
strategi
difficulttoventil
patient
would
otherwis
unlik
surviv
importantli
asthma
tradit
mechan
ventil
strategi
associ
volutrauma
barotrauma
due
high
pressur
requir
presenc
sever
bronchospasm
date
pauciti
data
ecmo
use
acut
asthma
unknown
whether
specif
clinic
inflammatori
characterist
associ
need
ecmo
perform
retrospect
review
adult
asthmat
requir
mechan
ventilatior
andor
ecmo
nearfat
asthma
admit
singl
larg
tertiari
hospit
clinic
demograph
data
includ
ventil
paramet
biochem
immunolog
indic
microbiolog
isol
record
compar
patient
requir
ecmo
patient
requir
convent
mechan
ventil
identifi
factor
significantli
associ
need
ecmo
data
includ
demograph
physiolog
laboratori
data
utilis
studi
collect
part
routin
acut
asthma
care
intens
care
unit
icu
tertiari
sever
asthma
centr
addit
ethic
approv
requir
patient
femal
age
year
primari
diagnosi
acut
asthma
associ
clinic
featur
nearfat
exacerb
requir
ecmo
mechan
ventil
includ
analysi
patient
requir
ecmo
requir
convent
mechan
ventil
compar
patient
requir
mechan
ventil
requir
ecmo
like
femal
versu
younger
mean
age
versu
year
prior
intervent
patient
requir
ecmo
higher
total
white
cell
count
versu
l
acidot
mean
ph
versu
p
hypercapn
mean
carbon
dioxid
tension
versu
kpa
p
statist
signific
differ
oxygen
oxygen
tension
creactiv
protein
crp
total
serum
immunoglobulin
e
blood
eosinophil
count
time
admiss
icu
observ
group
patient
requir
ecmo
like
posit
fungal
isol
bronchoalveolar
lavag
bal
fluid
requir
mechan
ventil
versu
rhinoviru
also
identifi
greater
proport
respiratori
isol
ecmo
cohort
compar
mechan
ventil
versu
strong
trend
toward
greater
likelihood
respiratori
viru
isol
ecmo
group
versu
differ
erspubl
patient
nearfat
asthma
requir
ecmo
like
younger
femal
also
like
posit
viral
fungal
isol
bronchoalveolar
lavag
compar
receiv
convent
mechan
ventil
http
cite
articl
patel
shah
nm
malhotra
et
al
inflammatori
microbiolog
associ
nearfat
asthma
requir
extracorpor
membran
oxygen
erj
open
re
incid
posit
bacteri
isol
compar
mechan
ventil
group
day
mechan
ventil
significantli
greater
ecmo
cohort
versu
day
addit
length
stay
lo
icu
versu
day
hospit
versu
day
p
significantli
longer
ecmo
group
higher
crp
level
admiss
hospit
associ
prolong
hospit
icu
stay
mechan
ventil
group
p
ecmo
patient
surviv
hospit
discharg
howev
two
mechan
ventil
patient
die
icu
admiss
retrospect
review
adult
asthmat
admit
intens
care
nearfat
acut
exacerb
report
requir
ecmo
associ
younger
age
femal
sex
presenc
either
fungal
rhinovir
infect
lower
airway
addit
higher
white
cell
count
profound
degre
hypercapnia
acidaemia
well
increas
lo
icu
hospit
overal
observ
requir
ecmo
support
find
may
suggest
possibl
complex
inflammatori
cascad
lead
lung
injuri
refractori
hypercapn
respiratori
failur
failur
mechan
ventil
review
clinic
note
ecmo
indic
case
due
maxim
mechan
ventilatori
support
reach
deem
extrem
detriment
individu
ie
lead
ventilatorinduc
lung
injuri
rather
overwhelm
infect
despit
find
patient
receiv
empir
antibacteri
andor
target
antiinfluenza
treatment
confirm
posit
deem
high
risk
admiss
hospit
antimicrobi
regim
rationalis
base
posit
isol
practic
common
respiratoryventilatori
failur
unexplain
deterior
singlesit
posit
isol
candida
speci
treat
case
fungaemia
antifung
therapi
start
presenc
rais
peripher
blood
marker
ie
high
index
suspicion
fungal
infect
patient
bal
isol
aspergillu
speci
treat
addit
collect
data
relat
prehospit
use
antimicrobi
therapi
studi
shown
viral
mediat
inflammatori
pathway
acut
quiescent
implic
nearfat
asthma
occur
much
patient
associ
fungal
isol
nearfat
asthma
novel
find
consist
associ
organ
acut
asthma
find
suggest
possibl
defect
antifung
andor
antivir
immun
pathway
patient
rhinoviru
well
recognis
trigger
acut
asthma
defici
antivir
type
interferon
report
asthma
limit
studi
retrospect
design
introduc
possibl
inform
bia
addit
import
clinic
background
characterist
includ
prior
exacerb
frequenc
inform
regard
adher
mainten
inhal
therapi
avail
howev
abl
partial
acquir
data
relat
prehospit
corticosteroid
use
tabl
data
found
greater
percentag
patient
without
formal
treatment
asthma
requir
ecmo
versu
interestingli
lower
percentag
patient
receiv
moder
highdos
inhal
corticosteroid
ic
andor
longact
requir
ecmo
compar
requir
mechan
ventil
moder
versu
high
versu
furthermor
patient
either
treatment
group
requir
longterm
oral
corticosteroid
biolog
agent
requir
ecmo
found
year
preced
acut
admiss
seven
receiv
regular
ic
document
regular
shortact
use
receiv
least
one
cours
oral
corticosteroid
data
shown
similar
data
mechan
ventilationonli
group
collect
therefor
cohort
comment
whether
level
treatment
associ
need
ecmo
note
patient
indic
asthma
corticosteroid
use
immunosuppress
form
thu
microbiolog
isol
unlik
influenc
secondari
factor
date
first
case
seri
investig
inflammatori
microbi
factor
associ
need
ecmo
nearfat
asthma
highlight
rhinoviru
infect
well
posit
fungal
isol
particularli
associ
need
ecmo
noteworthi
despit
sever
ill
inabl
mechan
ventil
patient
ecmo
associ
surviv
widespread
access
lifesav
therapi
made
prioriti
